USAQ Stock Overview
A medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
QHSLab, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.085 |
| 52 Week High | US$0.35 |
| 52 Week Low | US$0.02 |
| Beta | -0.67 |
| 11 Month Change | -43.33% |
| 3 Month Change | -43.14% |
| 1 Year Change | 150.00% |
| 33 Year Change | -86.92% |
| 5 Year Change | -57.50% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| USAQ | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -7.6% | 1.5% | 2.2% |
| 1Y | 150.0% | 20.8% | 31.6% |
Return vs Industry: USAQ exceeded the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: USAQ exceeded the US Market which returned 31.7% over the past year.
Price Volatility
| USAQ volatility | |
|---|---|
| USAQ Average Weekly Movement | 45.5% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: USAQ's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: USAQ's weekly volatility has decreased from 69% to 46% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 4 | Troy Grogan | www.usaqcorp.com |
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians.
QHSLab, Inc. Fundamentals Summary
| USAQ fundamental statistics | |
|---|---|
| Market cap | US$900.44k |
| Earnings (TTM) | -US$58.29k |
| Revenue (TTM) | US$1.82m |
0.5x
P/S Ratio-15.4x
P/E RatioIs USAQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USAQ income statement (TTM) | |
|---|---|
| Revenue | US$1.82m |
| Cost of Revenue | US$685.30k |
| Gross Profit | US$1.14m |
| Other Expenses | US$1.19m |
| Earnings | -US$58.29k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0055 |
| Gross Margin | 62.37% |
| Net Profit Margin | -3.20% |
| Debt/Equity Ratio | -515.9% |
How did USAQ perform over the long term?
See historical performance and comparison